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HIV-1 was recognized as the cause of AIDS in humans in 1984. Despite 30 years of intensive research, we are
still unraveling the molecular details of the host-pathogen interactions that enable this virus to escape
immune clearance and cause immunodeficiency. Here we explore a series of recent studies that consider
how HIV-1 interacts with the cell-autonomous innate immune system as it navigates its way in and out of
host cells. We discuss how these studies improve our knowledge of HIV-1 and host biology as well as in-
crease our understanding of transmission, persistence, and immunodeficiency and the potential for thera-
peutic or prophylactic interventions.
Open access under CC BY license.The Cell-Autonomous Innate Immune System
Like all viruses, lentiviruses parasitize their hosts and rely on a
complex interaction with host intracellular functions to complete
their life cycles. HIV-1 has evolved to recruit host dependency
factors, or cofactors, as well as evade or manipulate the cell-
autonomous innate immune system that has evolved over
millions of years to defend the host from infection. This defensive
system provides a mechanism by which cells can detect the
presence of a pathogen and also deploy a series of local and
systemic defensivemeasures that enhance andmediate antiviral
defenses. Importantly, the cell-autonomous innate immune
system also influences the adaptive immune system, providing
information on the nature of the pathogen and thus the appro-
priate adaptive response. The molecular tripwires of the cell-
autonomous innate immune system are pattern recognition
receptors (PRRs) that recognize pathogen-associated molecular
patterns (PAMPS) within the specific compartments that they
patrol. In this respect, principal cellular PRRs can be broadly
classified as transmembrane receptors of the Toll-like receptor
(TLR) family that sense extracellular or endosomal compart-
ments. There is also an increasing repertoire of cytoplasmic
receptors, mainly with specificity for pathogen nucleic acids as
well as nonmicrobial danger-associated molecular patterns.
The canonical response to PRR stimulation leads to activation
of signaling cascades and, typically, nuclear translocation of
cytoplasmic transcription factors exemplified by NF-kB RelA
and IRF3 with consequent transactivation of innate immune
response genes. In the antiviral response, this is dominated by
induction and secretion of soluble type 1 interferon (IFN). This
leads to autocrine, paracrine, or endocrine activation of cell
surface IFN receptors and downstream intracellular JAK/STAT
signaling cascade activation (Stark and Darnell, 2012), resulting
in a second line of gene expression changes that lead to
development of the so-called antiviral state. The antiviral state
is mediated by the combination of all the genes induced by the
IFN response and can comprise hundreds of proteins whose
expression is increased by exposure to IFN. In this way both
infected and nearby uninfected cells become nonpermissive10 Cell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc.to viral replication through expression of a host of diverse
antiviral activities that lead to the suppression of replication of
most viruses as well as other pathogens. In fact, the ability to
antagonize or evade this response is probably the most impor-
tant determinant for viral replication, or tropism, in a particular
host. Importantly, PRRs also lie upstream of the inflammasome,
in which caspase activation can unleash the function of inflam-
matory procytokines and initiate apoptosis or pyroptosis path-
ways, thereby coupling innate immune sensing of pathogens
to host cell death (Figure 1).
Although this robust IFN response is initiated, until recently the
suppression of HIV-1 replication by IFN and the characterization
of how HIV-1 avoids triggering IFN responses have been under-
studied. This is partly because IFN induces the expression of
many effector genes, making the system rather complicated
to dissect. However, studies examining the mechanisms under-
lying species-specific replication of lentiviruses as well as the
role of lentiviral accessory proteins have led to excellent prog-
ress in this field. This work uncovered IFN-stimulated factors
that restrict HIV, notably APOBEC3G (Sheehy et al., 2002),
TRIM5a (Stremlau et al., 2004), tetherin (Neil et al., 2008; Van
Damme et al., 2008), SAMHD1 (Hrecka et al., 2011; Laguette
et al., 2011), and more recently Mx2 (Goujon et al., 2013; Kane
et al., 2013). Many studies have shown that HIV-1 is sensitive
to IFN (Tsang et al., 2009), but it is only now becoming possible
to dissect the IFN effector systems using modern high-
throughput molecular approaches. For example, comparative
gene expression arrays were used to identify both tetherin
(Neil et al., 2008) and Mx2 (Goujon et al., 2013; Kane et al.,
2013). Here, we discuss recent progress in understanding how
HIV-1 interacts with the cell-autonomous innate immune system
and how this new knowledge could lead to new therapeutic
opportunities for viral infection and a better understanding of
HIV disease.
Cytoplasmic DNA Sensors that Detect HIV-1 Infection
Because retroviruses reverse transcribe their RNA genome into
double-stranded DNA in the cytoplasm of infected cells, innate
Figure 1. Innate Immune IFN Responses and Caspase-1-Mediated
Activation of Cytokines or Cell Death Are Functionally Coupled by
Upstream PRRs for Viral DNA
Sensors: cGAS, cGAMP synthase; IFI16, IFN-inducible protein 16; DAI, DNA-
dependent activator of IRFs; DDX41, DEAD Asp-Glu-Ala-Asp box polypeptide
41. Adapters and transcription factors: ASC, activating signal cointegrator 1;
STING, stimulator of IFN gene; NF-kB, nuclear factor kappa-light-chain-
enhancer of activated B cells; IRF3, IFN regulatory factor 3.
Figure 2. The Relationship between HIV-1, DNA Sensors, and IFN
Production Determines Successful Replication versus Abortive
Infection and Cell Death
(A–F) In macrophages, recruitment of host factors (CPSF6 and CypA) to the
HIV-1 capsid, shown as a blue border (A), and degradation of cytoplasmic viral
DNA by the exonuclease TREX1 (B) prevents IFN responses and allows HIV-1
to establish productive infection. Mutations in capsid or small molecule
inhibitors that prevent binding of CypA lead to IFN responses due to cGAS-
mediated detection of the DNA products of HIV-1 reverse transcription (RT)
even in the presence of TREX1 (C). In T cells, the sensing of incomplete RT
products by IFI16 led to activation of the inflammasome and caspase-1-
dependent cell death aswell as stimulation of the IFN responses (D). Cell death
in T cells has also been attributed to a DNA protein kinase (DNA PK)-depen-
dent DNA damage response that involves p53 and histone H2AX and results
from incomplete HIV-1 DNA integration events (E). Mx2 is an exemplar for the
antiviral effectors that are induced after sensing and that restrict viral infection.
Mx2 restricts HIV-1 nuclear entry, and no viral countermeasures are known (F).
Mx2 does not fully account for IFN-mediated restriction of wild-type HIV-1,
suggesting the presence of further, yet-unidentified restriction factors.
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problem for this family of viruses. Cytoplasmic DNA sensors
have received a great deal of attention recently. As a result, we
are beginning to understand the details of their sensing mecha-
nisms and the downstream consequences of their activation.
IFI16 is a cytoplasmic DNA sensor thought to have a role in
detection of specific viruses, including HIV-1 (Jakobsen et al.,
2013; Monroe et al., 2014), whose life cycle involves DNA in
the cytoplasm of infected cells (Unterholzner et al., 2010). How-
ever, the recently identified DNA sensor cGAS has generated
considerable attentionwith regard to HIV-1 infection. This sensor
synthesizes a second messenger molecule formed from cyclic
AMP and cyclic GMP called cGAMP (Wu et al., 2013), giving
rise to the name cGAMP synthetase, or cGAS, for the sensor
(Sun et al., 2013). The cGAMP produced by cGAS binds to
the adaptor molecule STING, leading to dimerization of the
transcription factor IRF3 and activation of IRF3-regulated genes
(Figure 1). Evasion of DNA sensors is thought to be particularly
important for lentiviruses, including HIV-1, not only because
they synthesize DNA in the cytoplasm of infected cells, but
also because they are particularly sensitive to the effects of
IFN. In most cases, lentiviruses are strongly repressed in cells
treated with type 1 IFN (Goujon and Malim, 2010; Tsang et al.,
2009). We therefore believe that HIV-1 is highly evolved to
avoid triggering DNA sensors, using a process we have termed
cloaking.
Evasion of DNA Sensors by Cloaking
In a series of studies from several labs, HIV-1 has been shown to
utilize cellular cofactors that allow evasion of DNA sensor activa-
tion and thereby prevent triggering of innate responses. In the
first example, the endoplasmic reticulum-associated nuclease
TREX1 was shown to be a critical cofactor for HIV-1 replication
(Yan et al., 2010) (Figure 2). At first, it seems paradoxical that a
nuclease that degrades HIV-1 DNA could act as a cofactor for
infection. However, in the absence of TREX1, excess cyto-plasmic DNA produced by reverse transcription appears to
trigger the cytoplasmic DNA sensor cGAS, leading to production
of the second messenger cGAMP (Gao et al., 2013; Sun et al.,
2013; Yan et al., 2010). cGAMP production leads to type 1 IFN
production, via STING activation, and suppression of replication.
Thus, HIV-1 appears to have evolved to synthesize DNA in such a
way that TREX1 degrades excess reverse transcription products
and prevents the virus from triggering cytosolic DNA sensors.
In individuals that are defective for TREX1, through genetic poly-
morphism, an autoinflammatory encephalitis manifests, called
Aicardi-Goutieres syndrome. This debilitating disease is charac-
terized by high levels of IFN production, thought to be due to
activation of DNA sensors by endogenous viruses (Stetson
et al., 2008). Thus, paradoxically, despite acting as a nuclease
and degrading viral DNA, TREX1 acts as a viral cofactor, pre-
venting HIV-1-mediated triggering of innate DNA sensors andCell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc. 11
Figure 3. Type 1 IFN May Have Positive and
Negative Effects Requiring Different
Therapeutic Strategies at Each Stage of the
Course of HIV-1 Disease
(A–C) Changes to CD4-positive T cells (CD4), type
1 IFN, and HIV-1 viral load (HIV VL) are represented
schematically over the course of HIV-1 infection.
We propose that HIV-1 goes under the radar of
innate immune detection and hence evades IFN
restriction in the eclipse phase that follows virus
inoculation (A), allowing it to establish a foothold in
host cells. The viremia that then arises from
massive virus propagation in T cells is associated
with significant T cell death and a systemic type 1
IFN response (B). Innate immune responses
that link induction of IFN and activation of the
inflammasome may contribute to the control of
viremia, but also mediate T cell death by py-
roptosis. Chronic IFN responses associated with
persistent viremia may contribute to progressive HIV-1 disease associated with chronic immune activation (C). The different roles for innate immune responses to
HIV-1 at each stage may offer specific therapeutic opportunities, such as enhancing innate immune detection by uncloaking the virus to reduce transmission
efficiency, targeting caspase-1 activation to reduce T cell death without compromising IFN-mediated restriction during primary HIV-1 disease, and inhibiting
HIV-1 induction of IFN in chronic infection to attenuate progressive disease.
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lates activation of cell-autonomous innate immunity, potentially
to the advantage of both endogenous and exogenous retro-
viruses. We assume that the evolutionarily advantageous rear-
rangement of genes provided by retrotransposition has led to
TREX1-mediated tolerance of cytoplasmic reverse transcription.
Although this pathway has evolved for use by the relatively unre-
lated, reverse-transcribing, endogenous retroelements, exoge-
nous retroviruses such as HIV-1 can exploit this tolerance.
HIV-1 Cloaking in Macrophages
We recently suggested that HIV-1 can replicate in humanmacro-
phages without triggering innate sensors because, in addition to
TREX1, the virus has evolved to utilize several additional cellular
cofactors to cloak its presence and avoid detection by PRRs
(Rasaiyaah et al., 2013) (Figure 2). HIV-1 recruits two particular
cofactors, cyclophilin A (CypA) and CPSF6, to the incoming
capsid (Franke et al., 1994; Lee et al., 2010; Price et al., 2012;
Towers et al., 2003). CypA is an abundant cytoplasmic prolyl
isomerase enzyme that recruits to the surface of the incoming
HIV-1 capsid and isomerizes the peptide bond between capsid
residues G89 and P90. CPSF6 also recruits to the HIV-1 capsid
while it is in the cytoplasm. CPSF6 is a predominantly nuclear
protein with a role in 30-end mRNA processing, which may
contribute to targeting HIV-1 into a particular pathway of nuclear
entry (Rasaiyaah et al., 2013). These cofactors are critical for
HIV-1 replication in primary human monocyte-derived macro-
phages (MDM) (Rasaiyaah et al., 2013). When interactions be-
tween CA and CypA or CPSF6 are prevented, such as by
mutating the viral capsid, HIV-1 triggers DNA sensors and acti-
vates a type 1 IFN response, leading to suppression of replica-
tion. Specifically, the HIV-1 capsid mutant N74D cannot recruit
CPSF6 and the P90A mutant capsid cannot recruit CypA.
HIV-1 encoding either of these mutations cannot replicate in
MDM due to simulation of type 1 IFN. The importance of IFN in
suppressing replication is illustrated by the fact that blockade
of IFN signaling using an IFN receptor antibody can rescue the
replication defect of the mutant viruses. The DNA sensor cGAS
appears to have a role in this process, as increased cGAMP12 Cell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc.was detected after infection of MDM with the P90A capsid
mutant. Similar levels of IFN secretion were elicited after RNAi-
mediated CPSF6 depletion and subsequent wild-type virus
infection or after prevention of CypA recruitment with a nonim-
munosuppressive cyclosporine, CsA-SmBz. This pharmaco-
logical uncloaking of HIV-1 suggests a new paradigm for the
treatment or prevention of viral infection in which viruses are
revealed to innate immune sensors by targeting cloaking cofac-
tors (Figure 3).
The observation that CPSF6 mutants with a defective nuclear
localization signal become cytoplasmic and can act as dominant
negatives that suppress HIV-1 reverse transcription (Hori et al.,
2013; Rasaiyaah et al., 2013) suggested that HIV-1 utilizes
CPSF6 to suppress premature DNA synthesis that would other-
wise trigger cytoplasmic DNA sensors. Why TREX1 is not able to
degrade the viral DNA responsible for DNA sensor triggering in
this case remains unclear, but may be due to the quantity, loca-
tion, or nature of the DNA products. For example, it is plausible
that TREX1-dependent DNA clearance is saturated, or that the
DNA products form specific immunostimulatory motifs (single-
or double-stranded or even RNA/DNA hybrids), which are resis-
tant to TREX1 degradation. The role of CypA is less clear than
CPSF6, but it may have a role in camouflaging the hexameric
lattice of HIV-1 capsid or an allosteric role in CPSF6 recruitment.
In summary, we hypothesize that HIV-1 recruits CypA and
CPSF6 to suppress premature reverse transcription and allow
evasion of DNA sensors in MDM (Hilditch and Towers, 2014).
Importantly, both CypA and CPSF6 were unnecessary for HIV-
1 replication in HeLa and HOS cell-based indicator cell lines.
This observation suggests that some cell lines may not have
intact DNA sensor pathways and may therefore be misleading
when examining cofactor dependence of HIV-1 or sensitivity to
innate immune sensors.
HIV-1 Uncoating and Reverse Transcription
Determine Cloaking
Early work characterizing the behavior of HIV-1 cores upon
target cell entry suggested that the viral cone-shaped capsid
containing the reverse transcription complex uncoats in the
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knowledge of DNA sensors and their ability to detect cyto-
plasmic DNA suggests that HIV may have evolved a more
sophisticated uncoating process that can evade DNA sensors,
at least in certain circumstances. Microscopic analysis of HIV-
1 behavior inside cells suggested that the virus might carry out
reverse transcription and uncoating in a highly organized way,
perhaps in complex with the nuclear pore, at least in some cells
(Arhel et al., 2007). More recent genetic analysis has described
multiple direct interactions between the HIV-1 capsid and nu-
clear pore proteins that might mediate this process. Functional
interactions have been described between the viral capsid and
nuclear pore components Nup358 (Bichel et al., 2013; Schaller
et al., 2011) and Nup153 (Matreyek and Engelman, 2011; Ma-
treyek et al., 2013) and perhaps interaction between integrase
and the karyopherin TNPO3 (Christ et al., 2008). Intriguingly,
Nup153 is largely found on the inside of the nuclear membrane
and yet appears to interact with HIV-1 capsid in the same pocket
asCPSF6 (Matreyek and Engelman, 2011;Matreyek et al., 2013).
Thus, one possibility is that Nup153 reaches through the nuclear
pore complex (NPC) from the nuclear side to displace CPSF6
and uncoat the intact reverse transcribing capsid. Such a model
might allow Nup153 to uncoat the viral core in the region asso-
ciated with the central pore of the NPC. This could allow the
DNA to be fed through the pore into the nucleus without being
exposed to the cytoplasm at any point, despite being synthe-
sized on the cytoplasmic side of the nuclear membrane. Nuclear
entry of the DNA is likely to be immediately followed by integra-
tion into chromatin, with nuclear entry and integration occurring
as a single coordinated event at the nuclear pore. An attractive
aspect of this more complex model of coordinated DNA synthe-
sis, uncoating, nuclear entry, and integration in complex with the
NPC is that it suggests a mechanism by which HIV-1 can evade
activation of the cell-autonomous innate immune system by
avoiding revealing viral DNA to cytoplasmic DNA sensors or
free viral DNA ends to the nuclear DNA damage machinery.
Antagonizing Restriction Factors while Traveling Light
In the case of lentiviruses, such as HIV-1, the IFN-induced
effector proteins that are actually responsible for suppressing
viral infectivity are called restriction factors. This phrase was
coined in the earliest days of considering the tropism of murine
leukemia viruses and their suppression by the restriction factor
Fv1 (Best et al., 1996). Most restriction factors are expressed
at low levels, even in the absence of IFN-mediated induction.
These proteins have therefore been described as mediating
intrinsic innate immunity because they are intrinsically expressed
(Bieniasz, 2004). However, distinguishing between proteins
based on their expression levels in uninduced cells may be
misleading, and we prefer to think of all IFN-induced proteins
as critical and integral features of the cell-autonomous innate
immune system.
Lentiviruses travel light, with only 9–10 genes. Because of this,
they do not have the genetic capacity to globally manipulate
innate immune responses as larger viruses do. For example,
herpes viruses encode in excess of 200 open reading frames,
the majority of which have roles in antagonizing cellular defen-
sive processes (for review, see Amsler et al., 2013). We hypoth-
esize that the constraints of a small genome provide selectivepressure for HIV-1 to evolve evasion strategies, rather than
antagonists that abrogate the effector functions of restriction
factors. However, because many restriction factors are intrinsi-
cally expressed, even in the absence of IFN induction, the virus
cannot simply inhibit the IFN pathway but must antagonize or
avoid specific restriction factors that pose a barrier to replication.
In the case of lentiviruses, accessory proteins carry the burden of
restriction factor antagonism. Indeed, it appears that the major
function of lentiviral accessory proteins is to act as adaptor
molecules that recruit ubiquitination machinery to mark the
targeted restriction factor for proteasome-mediated degradation
(Schwefel et al., 2014).
The restriction factor tetherin provides a good example of this
Red Queen-style antagonistic evolution between the host and
virus (Gupta et al., 2009a). Tetherin is a transmembrane protein
that forms a physical tether to prevent nascent HIV-1 virions
from leaving the surface of infected cells (Neil et al., 2008).
HIV-1 is unable to avoid budding through membranes and
therefore cannot avoid restriction by tetherin if the protein is
present in the host cell plasma membrane. The importance of
suppressing tetherin activity is illustrated by the fact that the
pandemic HIV-1 strain, HIV-1 M group, has evolved to use the
accessory Vpu protein to antagonize tetherin. The parental virus
SIVcpz from chimpanzees uses its Nef protein to antagonize
tetherin, and the less successful HIV-1 zoonoses, giving rise to
HIV-1 groups O, N, and P, have not made this evolutionary
transition as effectively and thus antagonize tetherin poorly
(Sauter et al., 2009). These observations suggest that tetherin
antagonism has been a critical aspect of the evolution of HIV-1
to become pandemic in humans (Gupta and Towers, 2009).
All other established primate lentiviruses also have antitetherin
activity. Most of the simian immunodeficiency viruses (SIVs),
like SIVcpz, use their Nef protein to antagonize tetherin, some
use Vpu, and some lentiviruses, notably HIV-2 and SIVtan
from Tantalus monkeys, can use their envelope protein for this
purpose (Gupta et al., 2009b; Le Tortorec and Neil, 2009).
The diversity of viruses restricted by tetherin has led to an
equally diverse array of antitetherin activities (for review, see
Neil, 2013).
The accessory gene Vif also has an important role antago-
nizing restriction factors in the shape of the APOBEC3 family of
cytidine deaminases (Sheehy et al., 2002). APOBEC3G, as well
as several other APOBEC3 proteins, suppresses HIV-1 infectivity
by inhibiting DNA synthesis as well as by driving catastrophic
hypermutation in any synthesized viral DNA. In this way, the
APOBEC proteins are powerful defensive restriction factors,
and the absence or failure of Vif to antagonize them via induced
degradation leads to potent suppression of viral replication.
SAMHD1 is a restriction factor expressed widely in myeloid
cell lineages and resting T cells (Baldauf et al., 2012; Laguette
et al., 2011). Restriction by SAMHD1 is mediated by reduction
of nucleotide pools to levels where reverse transcription cannot
proceed, although the restriction mechanismmay bemore com-
plex than this simple model (Goldstone et al., 2011; Lahouassa
et al., 2012). SAMHD1 appears to be particularly important for
protecting dendritic cells from HIV-1 infection (Manel et al.,
2010). SAMHD1 does not present a barrier to infection by
many SIVs because they encode the accessory protein Vpx,
which evolved by duplication of Vpr (Tristem et al., 1992). VpxCell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc. 13
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that leads to SAMHD1 ubiquitination and degradation by the
proteasome (Schwefel et al., 2014). HIV-1 does not encode a
Vpx homolog and is thus sensitive to restriction by SAMHD1.
This sensitivity has an important impact on HIV-1 tropism, with
evidence that SAMHD1 prevents HIV-1 infection of dendritic
cells and resting T cells (Baldauf et al., 2012; Laguette et al.,
2011). HIV-1 is not completely at the mercy of SAMHD1, how-
ever, because it can replicate in cells such as macrophages
despite the fact they express SAMHD1. Provision of Vpx to
HIV-1, either by coinfection with SIV or by manipulating HIV-1
such that it can incorporate the SIV protein (Sunseri et al.,
2011), improves HIV-1 infectivity in macrophages, and this con-
firms a functional role for SAMHD1 in these cells. However, HIV-1
can clearly replicate in macrophages without Vpx. Recent data
using a mouse SAMHD1 knockout demonstrated that HIV-1 be-
comes more sensitive to SAMHD1 in mouse cells if its reverse
transcriptase is mutated to have lower dNTP affinity. This obser-
vation suggests that wild-type HIV-1 partially escapes SAMHD1
by tolerating lower levels of nucleotides during DNA synthesis
(Rehwinkel et al., 2013). Whether this mechanism underpins
HIV-1 tropism for macrophages is not yet resolved.
Importantly, if SAMHD1 restriction is experimentally bypassed
in human dendritic cells, using SIV Vpx, then HIV-1 is able to
reverse transcribe. However, in this case the dendritic cells
detect the virus, become activated, and secrete large amounts
of type 1 IFN. Dendritic cells are therefore not permissive to a
full HIV-1 replication cycle, even when SAMHD1 restriction is
suppressed. An initial study suggested that this is because the
virus is detected by innate sensors acting after viral integration
and detecting a complex between the HIV-1 gag protein and
the cellular gag-binding cofactor CypA (Manel et al., 2010).
However, a more recent study from this group proposed that,
in fact, if SAMHD1 is inactivated with Vpx, then the cytoplasmic
DNA sensor cGAS detects HIV-1 reverse transcription products,
leading to activation of innate signaling cascades and the
maturation of the dendritic cells (Lahaye et al., 2013). This latter
model is more consistent with data derived in monocyte-derived
macrophages discussed above (Rasaiyaah et al., 2013).
Mx2 and Beyond
Consistent with the notion of innate evasion being important for
HIV-1, it is clear that the virus is unable to antagonize all of the
restriction factors that it encounters in the presence of type 1
IFN (Goujon and Malim, 2010; Tsang et al., 2009). This suggests
that the repertoire of IFN-induced effector proteins includes
yet-unidentified restriction factors with anti HIV-1 activity. The
search for new restriction factors active against HIV-1 has
recently revealed a role for the GTPase Mx2 in restricting HIV-
1 infection in IFN-treated cells (Figure 2). Almost simultaneously,
three independent groups identified Mx2 as having activity
against HIV-1 (Goujon et al., 2013; Kane et al., 2013; Liu
et al., 2013). Mx2 suppresses HIV-1 infectivity after reverse
transcription, possibly at the point of nuclear entry. The protein
localizes to the nuclear membrane and is therefore well posi-
tioned to suppress infection at this stage. Curiously, several
HIV-1 capsid mutants, including the CypA (CypA) binding
mutant P90A and the CPSF6 binding mutant N74D, have
been shown to be insensitive to Mx2 restriction, leading to sug-14 Cell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc.gestions of direct interactions between the capsid and Mx2.
However, at present, this possibility has not been rigorously
explored. Importantly, these HIV-1 capsid mutants are sensitive
to IFN treatment despite escaping Mx2, and IFN treatment of
most cells leads to a block to HIV-1 reverse transcription rather
than nuclear entry (Goujon and Malim, 2010). These obser-
vations point to the presence of further host factors capable
of suppressing HIV-1 DNA synthesis, and the search for the
proteins mediating the anti-HIV-1 effects of IFN remains as
competitive as ever.
Some Innate Immune Effectors Also Signal
One of the most exciting recent developments in the field of
lentiviral restriction is the realization that certain prototypic
anti-HIV-1 restriction factors can activate an innate response,
as well as act as antiviral effector molecules. These factors
therefore act as both innate sensors and IFN effectors. Avoiding
these proteins is presumed to be particularly important for
lentiviruses. This dual feature was described for TRIM5a in a
landmark publication in 2011 (Pertel et al., 2011). TRIM5a targets
incoming retroviral capsids, which it recruits to proteasomes,
shortly after viral entry, leading to a block to reverse transcription
and a process that dismantles the virus (Kutluay et al., 2013;
Stremlau et al., 2004). However, TRIM5a can also trigger an
innate signaling pathway when incoming virions are engaged,
acting like a classical PRR (Pertel et al., 2011). The innate signal
is dependent on TRIM5a ubiquitin ligase activity, which cata-
lyzes the synthesis of K63-linked ubiquitin chains, leading to
activation of TAK1 and NF-kB-dependent signaling pathways.
The HIV-1 capsid protein has evolved to be invisible to human
TRIM5a and is therefore not restricted by this protein, even
when expressed at high levels (Stremlau et al., 2004). Simian
TRIM5a proteins, however, have potent anti-HIV-1 activity, and
they pose a significant barrier to HIV-1 replication in nonhuman
species, particularly in Old World primates.
Like TRIM5a, tetherin also activates an innate signal on
engagement with newly formed virions activating an inflamma-
tory signaling that is similar in nature to that elicited by TRIM5a
engagement with virus (Gala˜o et al., 2012). The tetherin innate
signal is mediated by a tetherin variant expressed from an alter-
native AUG start codon. Two AUGs allow synthesis of a long
and a short tetherin, and while both of these proteins have
anti-HIV-1 activity, only the longer protein can generate an
innate signal (Cocka and Bates, 2012). Intriguingly, the gene-
ration of signaling capacity appears to be a unique property of
the human tetherin gene, and this activity is not found in the
chimpanzee or simian tetherin proteins. Thus, the ability to
generate an innate signal may be a recent adaptation that
allows tetherin to signal the presence of a pathogen to sur-
rounding uninfected cells. These observations suggest that in
some cases it might be as important for the infected cell to acti-
vate the cell-autonomous innate immune response as it is to kill
the detected virus. In this way, local cells at the site of infection
can be warned of impending infection, and an IFN-induced
antiviral state can be established before the virus infection
takes hold and becomes systemic. For a small IFN-sensitive
virus like HIV-1, antagonizing tetherin is likely to be particularly
important to prevent further augmentation of antiviral defenses,
particularly during transmission.
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Can the relationship between HIV-1 and the cell-autonomous
innate immune system help us to understand the pathogenesis
of HIV-1? Several recent studies have addressed this question
in some detail and have produced some surprising and exciting
findings that may have implications for our understanding of HIV
biology and the mechanism of immune deficiency. A series of
studies seeking to understand why HIV-1 causes T cell death
suggest that this relationship is key to understanding HIV-1 dis-
ease. The Greene lab has presented several studies that suggest
that incomplete reverse transcription products, produced in
abortively infected resting T cells, are detected by the DNA
sensor IFI16, leading to T cell death by pyroptosis (Doitsh
et al., 2010, 2014; Monroe et al., 2014) (Figure 2). The re-
searchers used mechanically disrupted tonsil explants for
these studies, reasoning that these primary human tissueswould
better represent the complexity of T cell subsets and the cyto-
kine milieu found in vivo (Doitsh et al., 2010). They discovered
that infection of these cultures with HIV-1 led to productive infec-
tion of a small percentage of the activated T cell fraction.
Remarkably, infection of this small number of cells led to a pro-
found loss of nonproductively infected T cells, with significant
loss of the resting cells that are traditionally thought to be
nonpermissive for HIV-1 infection. Loss of uninfected T cells
appeared to be dependent on viral fusion and incomplete
reverse transcription in the target cell cytoplasm. Killing was
most profound when the infected and uninfected cells were in
contact, suggesting a role for the viral synapse, although this
may simply reflect the increased efficiency of virus transfer in
the context of the synapse as opposed to cell-free virus. The
abortively infected dying cells displayed activated caspase-1,
activation of inflammasomes, and secretion of the potently in-
flammatory cytokine IL-1b (Doitsh et al., 2010). IL-1b production
and activation is tightly controlled, and secretion of bioactive IL-
1b requires activation of inflammasomes, which lead to cleavage
of the IL-1b precursor by caspase-1 and secretion of the bioac-
tive cytokine. CD4 T cells contain large amounts of IL-1b precur-
sor and are thus primed to activate this inflammatory response.
The DNA sensor responsible for caspase-1 activation in abor-
tively infected T cells appears to be IFI16 (Monroe et al., 2014).
The authors were able to purify IFI16 from tonsillar CD4 T cell ly-
sates using a 500 bp fragment of HIV-1 DNA as bait. Data sup-
porting a role for IFI16 in the activation of IL-1b production,
and the ensuing pyroptosis, were provided by IFI16 depletion ex-
periments using RNAi. IFI16 depletion led to a significant reduc-
tion in T cell death after HIV-1 infection as opposed to cultures
expressing a control hairpin. Tonsillar T cell cultures depleted
for AIM2 or STING were not protected from cell death after
HIV-1 infection, suggesting that these factors have no role in
the detection of abortive infection and caspase-1 activation.
Similar work in monocytes has suggested a role for SAMHD1
in sensing HTLV infection of these cells (Sze et al., 2013).
Importantly, investigation of the causes of T cell death
suggests a therapeutic opportunity for caspase-1 activation
with specific inhibitors. Indeed, caspase-1 inhibitors have been
developed and trialed in anticancer studies and are thus well
poised for clinical evaluation in HIV-1-infected patients. At
what stage of infection such an intervention may be effective
remains open to speculation (Figure 3). Importantly, T cell deathby pyroptosis was also reported in cultures of T cells isolated
from spleen, suggesting that these findings are not dependent
on the source of cells. Furthermore, both CCR5 and CXCR4
viruses were reported to be able to cause pyroptosis and IL-1b
production. While these results are yet to be reproduced inde-
pendently, we cautiously suggest that they may represent
a significant breakthrough in our understanding of how HIV-1
replication leads to T cell death and AIDS. An important question
that arises is whether SIV infection induces the same effect in
T cells purified from a species in which it is nonpathogenic.
For example, we might expect that SIVsm would not cause
pyroptosis in T cells from Sooty Mangabeys given that this virus
does not cause T cell depletion or disease in these animals
(Milush et al., 2011).
Work from the Nabel lab has suggested an additional mecha-
nism for cell death after HIV-1 infection (Cooper et al., 2013).
In this case, cell death was shown to be due to incomplete inte-
gration events, rather than sensing of incomplete reverse tran-
scription products (Figure 2). In this system, cell death involved
the triggering of DNA-dependent protein kinase (DNA-PK), a
critical component of the DNA damage response, and was
observed in a T cell line (CEMX174) as well as primary T cells
derived from HIV patient PBMC. Additional studies indicated
that the route of viral entry is unimportant for triggering DNA-
PK and that neither viral gene expression nor RNA export is
required to induce cell death in thismodel. The integrase inhibitor
Raltegravir effectively protected cells from death, consistent
with an important role for integration. DNA circularization was
not thought to be important in this context because depletion
of DNA ligase 4, an enzyme required for DNA circle formation,
did not impact cell death, although DNA circles were reduced
as expected. Investigating the mechanism of induction of cell
death, the authors detected HIV-1 integration-dependent phos-
phorylation of p53 and histone H2AX. Furthermore, DNA-PK
localized to the nuclei of the infected cells. The authors con-
cluded that HIV-1 integration elicits a cellular double-stranded
DNA damage response that leads to virus-induced cell death.
This process was sensitive to pharmacological inhibition, and
DNA-PK inhibitors prevented p53 and H2AX phosphorylation
and HIV-1-dependent cell death in both T cell lines and primary
CD4+ lymphocyte cultures. Again, these observations require
independent reproduction, but they suggest a further possibility
for the cause of T cell death induced by HIV-1. Strikingly, it is
the defensive processes of the innate immune system that
appear to be the cause of cell death in both of these narratives
(Figures 1 and 2).
The Role of Type 1 IFN
Despite the stealth HIV-1 has evolved in its replication in macro-
phages, it is not capable of universally avoiding triggering IFN
production. During primary viremia, HIV-1 causes a wave of
infection through the T cell compartment in the mucosal tissues
of the gut, and the emergent viremia in primary HIV-1 infection
is associated with a cytokine storm (Stacey et al., 2009) that
might contribute to some degree of virus restriction, but ulti-
mately fails to sterilize infection (Figure 3). This cascade of
inflammatory cytokines includes high levels of type 1 IFN. The
prevailing view implicates a role for TLR7-dependent induction
of IFN in plasmacytoid dendritic cells (Lepelley et al., 2011) andCell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc. 15
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fected T cells may also produce type 1 IFN (Doitsh et al., 2014).
Are Macrophages Important in HIV-1 Pathogenesis?
Together, the studies described above suggest that HIV-1 may
cause more cell death while replicating in T cells than it does
when replicating in macrophages. This could be interpreted as
HIV-1 being better adapted to replicate in macrophages than
in T cells. However, it remains somewhat controversial as to
whether macrophages represent a significant target cell type
for HIV-1 in vivo. We argue that, while it is undeniably true that
the vast majority of HIV-1 replication occurs in T cells, macro-
phages may nonetheless represent an important target cell
type. While almost all the virus in an infected individual is derived
from T cells, it seems pertinent that HIV-1 has evolved to repli-
cate in macrophages without triggering cytokine production or
cell death. We propose that if it did not avoid triggering IFN
responses in these and other myeloid cells, then this would
have significant negative consequences on its ability to transmit
and replicate to high levels. For example, dendritic cells are not
thought to be permissive for HIV-1 replication, yet their infection
likely has profound effects on the consequences of HIV-1 infec-
tion, and their ability to sense HIV-1 has a critical role in this
process (for review, see Luban, 2012).We imagine that HIV-1 be-
haves differently in different cell types, perhaps due to different
cofactor availability or cofactor requirements, and further, that
the characterization of the differences and similarities between
replication in these cell types will be critical for a full understand-
ing of transmission and pathogenesis aswell as the development
of new therapeutics and vaccines.
A Role for IFN in HIV-1 Transmission
Further support for the importance of IFN in inhibiting HIV and
thus potentially limiting transmission comes from the study of
HIV-1-transmitted founder clones. The viral clones that are
responsible for transmitting from one individual to another
appear to have been selected for the maximal level of insen-
sitivity to IFN (Fenton-May et al., 2013). High-throughput
sequencing of virus from patients at very early stages of infection
allows the construction of what are referred to as transmitted
founder clones. These virus clones represent the virus that actu-
ally transmitted to the patient, and infection can often be shown
to be due to a single clone of founder virus (Salazar-Gonzalez
et al., 2009). Comparing IFN sensitivity of transmitted founder
clones with clones derived from the same patients several years
later revealed that the founder clones are significantly less sen-
sitive to IFN than their chronic clone counterparts (Fenton-May
et al., 2013). This suggests that the virus becomesmore sensitive
to IFN between peak viremia and chronicity and is consistent
with a selective event during transmission that favors virus that
is most insensitive to IFN. Many studies have shown that HIV-1
transmission is a rare event, with many exposures required for
each successful event. For example, conservative estimates
suggest as many as 100 exposures for each case of HIV-1 infec-
tion. An ability to avoid triggering IFN and at the same time be
relatively resistant to any IFN that is produced therefore appear
to be key features of successfully transmitted viral clones.
We therefore hypothesize that HIV-1 is a virus with the
capacity to trigger IFN and a particular sensitivity to IFN, partic-16 Cell Host & Microbe 16, July 9, 2014 ª2014 Elsevier Inc.ularly in the mucosa where target cells are more likely to be
myeloid than lymphocytic. These features may combine to
make transmission a rare event that depends on limited sensi-
tivity to IFN and a quiet approach where innate sensors are
concerned. Once transmission has occurred and the virus
begins to replicate in activated T cells in the gut, then IFN
sensitivity may become less of a problem. We hypothesize
that IFN is a good thing for the host at the point of transmission
because it induces protective responses. IFN may also be
beneficial to the host during primary viremia, where it may
help suppress viral replication. However, it seems likely that
continuous low-level IFN production during the chronic stage
of infection is likely to be detrimental to the host and contribute
to disease (Figure 3), for example by promoting TRAIL-medi-
ated bystander apoptosis of CD4 T cells (Barblu et al., 2012;
Hardy et al., 2007; Stary et al., 2009). Certainly, prolonged
immune activation is associated with lentiviral infections that
cause disease over ones that don’t (Evans and Silvestri,
2013). However, our model of IFN-sensitive transmission is an
optimistic one. Tipping the balance in favor of IFN and virus
suppression should be relatively easy once we have a detailed
understanding of HIV-1 evasion strategies and IFN effector
mechanisms. Uncloaking the virus pharmacologically could
be an effective prophylactic, for example by using nonimmuno-
suppressive cyclosporines (Rasaiyaah et al., 2013). Route of
transmission will be important, of course, and it may be more
difficult to prevent infection caused by direct injection of virus
or infected cells as is the case with shared needle transmis-
sions. Differences between vaginal and rectal tissues will also
influence the effectiveness of any intervention depending on a
mucosal environment.
The Study of SIV in Nonhuman Primates
Lentiviruses are prevalent natural infections of certain African
nonhuman primates, but natural infection of monkeys, with their
cognate SIV, does not generally lead to significant pathogenicity.
The reasons for the lack of disease after natural SIV infection are
unclear, but many studies have highlighted high levels of immune
activation as a key feature of pathogenic versus nonpathogenic
lentiviral infections. Immune activation also strongly correlates
with disease in primate models of AIDS in which monkeys, usu-
ally Asian macaques, are infected with lentivirus from another
species, for example SIVsm lineage viruses. In these cases,
infection can lead to an AIDS-like disease very similar to that
seen in humans. Natural infection of Sooty Mangabeys with
SIVsm, however, does not lead to significant immune activation,
and infected animals are largely asymptomatic, despite high viral
loads in peripheral blood. The continued study of natural,
nonpathogenic, lentiviral infection and its comparison to AIDS
in humans and experimentally infected monkeys promises to
reveal a great deal of the mechanisms of lentiviral pathogenesis
(Evans and Silvestri, 2013). We advise some caution in using SIV
to study transmission because the route of SIV transmission is
likely to differ from HIV-1, which may have specifically adapted
to become a sexually transmitted disease. Comparison between
SIV and HIV-1 must also take into account the fact that SIV
encodes Vpx, whereas HIV-1 does not, and the tropism for
myeloid cells such as dendritic cells that SIV gains through this
additional feature.
Cell Host & Microbe
ReviewConcluding Remarks
The balance between evading host induction of type 1 IFN and
suppression of HIV-1 by IFN will be critical to both transmission
events as well as subsequent viral replication. A better under-
standing of how HIV-1 cloaks itself to avoid sensing may help
us develop inhibitors of cloaking that can act as powerful
prophylactics (Rasaiyaah et al., 2013). Further, discovering the
identity of the restriction factors that suppress HIV-1 replication
when sensors are activated and IFN is produced will provide
important details of the virus’s weak spots, particularly during
transmission. We hope that eventually this work will lead to our
ability to eradicate the virus from an infected individual and elicit
a lasting cure for this obstinate viral pathogen.
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